Eagle Strategies’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $315K | Buy |
2,603
+33
| +1% | +$3.99K | 0.05% | 189 |
|
|
2025
Q1 | $286K | Hold |
2,570
| – | – | 0.05% | 183 |
|
|
2024
Q4 | $250K | Hold |
2,570
| – | – | 0.04% | 197 |
|
|
2024
Q3 | $296K | Hold |
2,570
| – | – | 0.05% | 168 |
|
|
2024
Q2 | $274K | Buy |
+2,570
| New | +$274K | 0.05% | 176 |
|
|
2024
Q1 | – | Sell |
-2,534
| Closed | -$256K | – | 315 |
|
|
2023
Q4 | $256K | Hold |
2,534
| – | – | 0.05% | 168 |
|
|
2023
Q3 | $258K | Hold |
2,534
| – | – | 0.06% | 159 |
|
|
2023
Q2 | $256K | Hold |
2,534
| – | – | 0.06% | 161 |
|
|
2023
Q1 | $233K | Buy |
2,534
+29
| +1% | +$2.67K | 0.06% | 165 |
|
|
2022
Q4 | $227K | Buy |
+2,505
| New | +$227K | 0.07% | 158 |
|
|
2022
Q3 | – | Sell |
-2,544
| Closed | -$215K | – | 130 |
|
|
2022
Q2 | $215K | Sell |
2,544
-30
| -1% | -$2.54K | 0.08% | 130 |
|
|
2022
Q1 | $226K | Buy |
2,574
+50
| +2% | +$4.39K | 0.09% | 129 |
|
|
2021
Q4 | $221K | Buy |
+2,524
| New | +$221K | 0.09% | 135 |
|